← Back to all trials
Active Not Recruiting
NCT05663073
Pharmacokinetics of Irbesartan/Amlodipine FDC and Co-administration of Irbesartan and Amlodipine in Healthy Volunteers
Conditions: Healthy Volunteers
Sex: All
Ages: 19 Years – N/A
Healthy volunteers: 1
Phase: PHASE1
Enrollment: 46
Sponsor: Handok Inc.
Location: Korea, Republic of
Summary
The purpose of this study is to compare pharmacokinetics and safety of Irbesartan and Amlodipine Fixed Dose Combination and coadministration of mono compounds in healthy adult volunteers
Eligibility Criteria
Inclusion Criteria:Patients who are 19 years or older on screeningSigned informed consentHealthy VolunteerOther inclusion appliesExclusion Criteria:Clinically relevant/significant findings as evaluated by the investigatorOther exclusion applied
Source: ClinicalTrials.gov (NCT05663073). StuddyBuddy aggregates publicly available trial information.
